Scan to Download
One power score. Smarter investment decisions
ARS Pharmaceuticals Inc
SPRY9.720USD
-0.080-0.82%
Close 09/29, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000After-hours 09/30, 20:00 (ET)
959.34MMarket Cap
LossP/E TTM
ARS Pharmaceuticals Inc
9.720
-0.080-0.82%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Total revenue
3043.40%15.72M
--7.97M
--86.58M
--2.07M
4900.00%500.00K
-100.00%0.00
-100.00%0.00
--0.00
--10.00K
--20.00K
--1.32M
----
----
----
----
----
----
----
----
----
----
Revenue
3043.40%15.72M
--7.97M
--86.58M
--2.07M
4900.00%500.00K
-100.00%0.00
-100.00%0.00
--0.00
--10.00K
--20.00K
--1.32M
----
----
----
----
----
----
----
----
----
----
Cost of revenue
--4.98M
--1.09M
--865.00K
--112.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
299.82%63.33M
242.25%45.15M
285.14%39.38M
32.47%23.82M
-23.16%15.84M
-29.58%13.19M
141.60%10.23M
-2.92%17.98M
10.81%20.61M
-22.89%18.73M
-204.58%-24.58M
-18.35%18.52M
-24.11%18.60M
28.64%24.29M
79.43%23.51M
--22.68M
--24.51M
260.26%18.89M
89.02%13.10M
--5.24M
--6.93M
R&D expenses
-41.49%4.04M
-43.60%2.95M
-11.08%3.03M
47.34%4.42M
-5.64%6.90M
-20.12%5.23M
155.15%3.40M
-63.67%3.00M
-35.71%7.31M
-60.47%6.55M
-138.89%-6.17M
-47.17%8.26M
-35.95%11.37M
35.42%16.57M
79.60%15.87M
--15.64M
--17.75M
177.28%12.24M
40.87%8.84M
--4.41M
--6.27M
Depreciation, depletion, and amortization
1450.00%279.00K
2445.45%280.00K
141.67%29.00K
0.00%21.00K
-10.00%18.00K
-45.00%11.00K
--12.00K
-79.41%21.00K
-91.07%20.00K
-90.34%20.00K
----
-49.75%102.00K
8.21%224.00K
11.29%207.00K
-1.06%187.00K
--203.00K
--207.00K
33.81%186.00K
36.96%189.00K
--139.00K
--138.00K
Other operating expenses
----
----
----
----
----
----
----
----
----
----
---15.30M
----
----
----
----
----
----
----
----
----
----
Operating profit
-210.39%-47.61M
-181.81%-37.18M
561.54%47.20M
-20.97%-21.75M
25.54%-15.34M
29.50%-13.19M
-139.48%-10.23M
2.92%-17.98M
-10.76%-20.60M
22.97%-18.71M
210.18%25.90M
18.35%-18.52M
24.11%-18.60M
-28.64%-24.29M
-79.43%-23.51M
---22.68M
---24.51M
-260.26%-18.89M
-89.02%-13.10M
---5.24M
---6.93M
Net non-operating interest income (expenses)
Special income (expenses)
----
----
----
----
----
----
-100.00%0.00
----
----
----
--1.56M
---100.00K
---1.20M
---404.00K
----
----
----
----
----
----
--0.00
- Gains from disposal of fixed assets
----
----
----
----
----
----
----
----
----
----
--320.00K
---320.00K
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-3.29%2.73M
11.62%3.24M
-1.08%3.02M
-15.81%2.62M
-12.65%2.82M
-22.71%2.90M
213.96%3.06M
--3.11M
--3.23M
--3.75M
--974.00K
----
----
----
----
----
----
----
----
----
----
Income before tax
-258.60%-44.88M
-229.77%-33.94M
800.64%50.22M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-126.31%-7.17M
16.78%-14.87M
10.60%-17.37M
39.26%-14.96M
216.12%27.24M
21.15%-17.86M
20.69%-19.43M
-30.55%-24.63M
-79.29%-23.46M
---22.66M
---24.50M
-257.40%-18.87M
-87.73%-13.09M
---5.28M
---6.97M
Income tax
----
----
--288.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-258.60%-44.88M
-229.77%-33.94M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-126.31%-7.17M
16.78%-14.87M
10.60%-17.37M
39.26%-14.96M
216.12%27.24M
21.15%-17.86M
20.69%-19.43M
-30.55%-24.63M
-79.29%-23.46M
---22.66M
---24.50M
-257.40%-18.87M
-87.73%-13.09M
---5.28M
---6.97M
Net income from continuous operations
-258.60%-44.88M
-229.77%-33.94M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-126.31%-7.17M
16.78%-14.87M
10.60%-17.37M
39.26%-14.96M
216.12%27.24M
21.15%-17.86M
20.69%-19.43M
-30.55%-24.63M
-79.29%-23.46M
---22.66M
---24.50M
-257.40%-18.87M
-87.73%-13.09M
---5.28M
---6.97M
Net income attributable to controlling interests
-258.60%-44.88M
-229.77%-33.94M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-126.31%-7.17M
16.78%-14.87M
10.60%-17.37M
39.26%-14.96M
216.12%27.24M
21.15%-17.86M
20.69%-19.43M
-30.55%-24.63M
-79.29%-23.46M
---22.66M
---24.50M
-257.40%-18.87M
-87.73%-13.09M
---5.28M
---6.97M
Net income attributable to common shareholders
-258.60%-44.88M
-229.77%-33.94M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
-126.31%-7.17M
16.78%-14.87M
10.60%-17.37M
39.26%-14.96M
216.12%27.24M
21.15%-17.86M
20.69%-19.43M
-30.55%-24.63M
-79.29%-23.46M
---22.66M
---24.50M
-257.40%-18.87M
-87.73%-13.09M
---5.28M
---6.97M
Basic earnings per share
-253.02%-0.46
-224.47%-0.35
787.61%0.51
-26.74%-0.20
29.37%-0.13
32.82%-0.11
-114.80%-0.07
69.13%-0.16
66.91%-0.18
77.36%-0.16
175.27%0.50
22.16%-0.50
21.25%-0.55
-29.29%-0.70
-102.58%-0.67
---0.65
---0.70
-257.39%-0.54
-56.74%-0.33
---0.15
---0.21
Diluted earnings per share
-253.02%-0.46
-224.47%-0.35
661.78%0.42
-26.74%-0.20
29.37%-0.13
32.82%-0.11
-114.80%-0.07
69.13%-0.16
66.91%-0.18
77.36%-0.16
175.27%0.50
22.16%-0.50
21.25%-0.55
-29.29%-0.70
-102.58%-0.67
---0.65
---0.70
-257.39%-0.54
-56.74%-0.33
---0.15
---0.21
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
